Enavatuzumab, a Humanized Anti-TWEAK Receptor Monoclonal Antibody, Exerts Antitumor Activity through Attracting and Activating Innate Immune Effector Cells

Enavatuzumab, a Humanized Anti-TWEAK Receptor Monoclonal Antibody, Exerts Antitumor Activity through Attracting and Activating Innate Immune Effector Cells

Enavatuzumab is a humanized IgG1 anti-TWEAK receptor monoclonal antibody that was evaluated in a phase I clinical study for the treatment of solid malignancies. The current study was to determine whether and how myeloid effector cells were involved in postulated mechanisms for its potent antitumor a...

Full description

Bibliographic Details
Main Authors:	Shiming Ye, Melvin I. Fox, Nicole A. Belmar, Mien Sho, Debra T. Chao, Donghee Choi, Yuni Fang, Vivian Zhao, Stephen F. Keller, Gary C. Starling, Patricia A. Culp
Format:	Article
Language:	English
Published:	Hindawi Limited 2017-01-01
Series:	Journal of Immunology Research
Online Access:	http://dx.doi.org/10.1155/2017/5737159

Similar Items

Nuclear Factor κB is required for tumor growth inhibition mediated by enavatuzumab (PDL192), a humanized monoclonal antibody to TweakR
by: James W. Purcell, et al.
Published: (2014-01-01)

TWEAK/Fn14 Activation Participates in Skin Inflammation
by: Qilu Liu, et al.
Published: (2017-01-01)

Diosgenin Exerts Antitumor Activity via Downregulation of Skp2 in Breast Cancer Cells
by: Yanling Liu, et al.
Published: (2020-01-01)

Transgenic plants of Nicotiana tabacum L. express aglycosylated monoclonal antibody with antitumor activity
by: Meilyn Rodríguez, et al.

Tweaking microtubules to treat scleroderma.
by: Jacob M van Laar, et al.
Published: (2005-12-01)

TWEAK promotes peritoneal inflammation.
by: Ana Belen Sanz, et al.
Published: (2014-01-01)

Tweaking microtubules to treat scleroderma.
Published: (2005-12-01)

Urinary TWEAK Level as a Marker of Lupus Nephritis Activity in 46 Cases
by: Zhu Xuejing, et al.
Published: (2012-01-01)

Exploration and Optimization of Cyclohexane-based Tetraindoles Exerting Antitumor Activity against Cancer Cell Lines
by: YEN, HUNG-CHI, et al.
Published: (2018)

Silybin-mediated inhibition of Notch signaling exerts antitumor activity in human hepatocellular carcinoma cells.
by: Song Zhang, et al.
Published: (2013-01-01)

Ficus umbellata Vahl. (Moraceae) Stem Bark Extracts Exert Antitumor Activities In Vitro and In Vivo
by: Kevine Kamga Silihe, et al.
Published: (2017-05-01)

Immunization of Fucose-containing Polysaccharides from Reishi Mushroom Exerts Antibody-mediated Antitumor Activity
by: Shih-Fen Liao, et al.
Published: (2013)

Novel Pan-Pim Kinase Inhibitors With Imidazopyridazine and Thiazolidinedione Structure Exert Potent Antitumor Activities
by: Yuichi Sawaguchi, et al.
Published: (2021-05-01)

A new compound Trichomicin exerts antitumor activity through STAT3 signaling inhibition
by: Fengchang Zhu, et al.
Published: (2020-01-01)

TWEAKing the Hippocampus: The Effects of TWEAK on the Genomic Fabric of the Hippocampus in a Neuropsychiatric Lupus Mouse Model
by: Dumitru A. Iacobas, et al.
Published: (2021-07-01)

Molecular Mechanisms of Antitumor Activity of PAMAM Dendrimer Conjugates with Anticancer Drugs and a Monoclonal Antibody
by: Monika Marcinkowska, et al.
Published: (2019-08-01)

The role of EGR-1 and calcium influx in the antitumor activity of anti-CD20 monoclonal antibodies
by: Spasevska, Ivana
Published: (2017)

LYG1 exerts antitumor function through promoting the activation, proliferation, and function of CD4+ T cells
by: Huihui Liu, et al.
Published: (2017-04-01)

Downregulation of Notch-regulated Ankyrin Repeat Protein Exerts Antitumor Activities against Growth of Thyroid Cancer
by: Bing-Feng Chu, et al.
Published: (2016-01-01)

TM5614, an Inhibitor of Plasminogen Activator Inhibitor-1, Exerts an Antitumor Effect on Chronic Myeloid Leukemia
by: Fujiwara, T., et al.
Published: (2022)

Pterostilbene exerts antitumor activity via the Notch1 signaling pathway in human lung adenocarcinoma cells.
by: Yang Yang, et al.
Published: (2013-01-01)

Huangqi Fuzheng decoction exerts antitumor activity by inhibiting cell growth and inducing cell death in osteosarcoma
by: Jinghao Qin, et al.
Published: (2019-06-01)

Aloperine Exerts Antitumor Effects on Bladder Cancer in vitro
by: Zhang L, et al.
Published: (2020-10-01)

Juglone exerts antitumor effect in ovarian cancer cells
by: Fang Fang, et al.
Published: (2015-06-01)

Inhibition of lipid metabolism exerts antitumor effects on rhabdomyosarcoma
by: Satoshi Miyagaki, et al.
Published: (2021-09-01)

Consuming audio: An introduction to Tweak Theory
by: Perlman, Marc
Published: (2014-09-01)

TWEAK Negatively Regulates Human Dicer
by: Marine Lambert, et al.
Published: (2016-10-01)

TWEAK and Fn14 in the neurovascular unit
by: Manuel eYepes
Published: (2013-11-01)

The role of ubiquitination in TWEAK stimulated signaling
by: Domagoj eVucic
Published: (2013-12-01)

TWEAK/Fn14 signaling in tumors
by: Guanglei Hu, et al.
Published: (2017-06-01)

Nitric Oxide Synthase Type III Overexpression By Gene Therapy Exerts Antitumoral Activity In Mouse Hepatocellular Carcinoma
by: Raúl González, et al.
Published: (2015-08-01)

TMPYP4 exerted antitumor effects in human cervical cancer cells through activation of p38 mitogen-activated protein kinase
by: Ming-Jun Cheng, et al.
Published: (2017-07-01)

TWEAK/Fn14 Activation Participates in Ro52-Mediated Photosensitization in Cutaneous Lupus Erythematosus
by: Yale Liu, et al.
Published: (2017-05-01)

Proteolytic single hinge cleavage of pertuzumab impairs its Fc effector function and antitumor activity in vitro and in vivo
by: Hao-Ching Hsiao, et al.
Published: (2018-06-01)

Tweaking Progranulin Expression: Therapeutic Avenues and Opportunities
by: Joke Terryn, et al.
Published: (2021-07-01)

Tweaking one-loop determinants in AdS3
by: Alejandra Castro, et al.
Published: (2017-10-01)

TWEAK: a new player in obesity and diabetes
by: Joan J Vendrell, et al.
Published: (2013-12-01)

Weak Tweak-Keys for the CRAFT Block Cipher
by: Leander, G., et al.
Published: (2022)

Taking the Hinge off: An Approach to Effector-Less Monoclonal Antibodies
by: Jamie Valeich, et al.
Published: (2020-09-01)

A Novel Monoclonal Antibody Targeting Cancer-Specific Plectin Has Potent Antitumor Activity in Ovarian Cancer
by: Samantha M. Perez, et al.
Published: (2021-08-01)

Cannot write session to /tmp/vufind_sessions/sess_t7s2kd10e7c52oc1jebq76itbr